1. Chiruta V (2022) Freedom of Information: Psilocybin and MDMA Therapeutic Use Approvals. Available at: https://www.ifta.org.au/post/psilocybin-and-mdma-therapeutic-use-approvals.
2. Compassionate use of psychedelics
3. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
4. Mind Medicine Australia (MMA) (2020a) Application to Reschedule N,ɑ-DIMETHYL-3,4 (METHYLENEDIOXY)PHENYLETHYLAME (MDMA) from Schedule 9 to Schedule 8 of the Poison Standards. Available at: https://mindmedicineaustralia.org.au/wp-content/uploads/MMA-MDMA-Rescheduling-S9-to-S8-15-July-2020-FINAL.pdf.
5. Mind Medicine Australia (MMA) (2020b) Application to Reschedule Psilocybine1 from Schedule 9 to Schedule 8 of the Poison Standards. Available at: https://mindmedicineaustralia.org.au/wp-content/uploads/MINDME1.pdf.